Twitter accused of infringing IBM patents days before IPO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Twitter accused of infringing IBM patents days before IPO

Twitter has received a letter from IBM accusing it of infringing at least three IBM patents just days before the social networking site's Initial Public Offering

The allegation was revealed by Twitter in an S-1 filing used by companies to register their assets with the US Securities and Exchange Commission (SEC). In the letter sent by IBM, the technology company invited Twitter's executives "to negotiate a business resolution of the allegations".

The patents in question are US Patent No 6,957,224, which covers the efficient retrieval of uniform resource locators; No 7,072,849, which protects a method for presenting advertising in an interactive service; and No 7,099,862, which relates to programmatic discovery of common contacts.

In filing, Twitter admits that its IP portfolio is smaller than that of many of its competitors, and notes that NPEs "often attempt to aggressively assert claims in order to extract value from technology companies".

But the company says of the IBM letter: "We believe we have meritorious defenses to IBM's allegations, although there can be no assurance that we will be successful in defending against these allegations or reaching a business resolution that is satisfactory to us".

Despite the accusation, Twitter said in the SEC filing that it plans to offer its stock for between $23 and $25 a share - up from the previous asking price of between $17 and $20. The increase values the company at $17 billion, compared to the previous valuation of $11 billion.



more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article